Human β2-adrenergic receptor/GSα fusion protein, expressed in 2 ras-dependent murine carcinoma cell lines, prevents tumor growth in syngeneic mice

International Journal of Cancer

Volumn 71, Issue 6, 1997, Pages 1029-1034

  Bertin, Brigitte ^a,b   Strosberg, A Donny ^a   Marullo, Stefano ^a  

^a INSTITUT COCHIN   (France)

^b INSTITUT DE PHARMACOLOGIE ET DE BIOLOGIE STRUCTURALE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

3 ISOPROPYLAMINO 1 (7 METHYL 4 INDANYLOXY) 2 BUTANOL; BETA 2 ADRENERGIC RECEPTOR; FORSKOLIN; HYBRID PROTEIN; ICI 118715; ISOPRENALINE; SALMETEROL; STIMULATORY GUANINE NUCLEOTIDE BINDING PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CARCINOMA CELL; CONTROLLED STUDY; GENE EXPRESSION; GROWTH INHIBITION; MOUSE; NONHUMAN; ONCOGENE RAS; PRIORITY JOURNAL; ANIMAL; C57BL MOUSE; CELL CLONE; CELL CULTURE; CELL DIVISION; EXPERIMENTAL NEOPLASM; GENE THERAPY; GENETICS; HUMAN; IMMUNOLOGY; IMMUNOTHERAPY;

ANIMALS; CELL DIVISION; CLONE CELLS; GENE THERAPY; GENES, RAS; GTP-BINDING PROTEIN ALPHA SUBUNITS, GS; HUMANS; IMMUNOTHERAPY; MICE; MICE, INBRED C57BL; NEOPLASMS, EXPERIMENTAL; RECEPTORS, ADRENERGIC, BETA-2; RECOMBINANT FUSION PROTEINS; TUMOR CELLS, CULTURED;

EID: 0030610252     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19970611)71:6<1029::AID-IJC19>3.0.CO;2-8     Document Type: Article

References (25)

1. ABRAMS, S.I., HAND, P.M., TSANG, K.Y. and SCHLOM, J., Mutant ras epitopes as targets for cancer vaccines. Semin. Oncol., 23, 118-134 (1996).
2. BERTIN, B., FREISSMUTH, M., JOCKERS, R., STROSBERG, A.D. and MARULLO, S., Cellular signaling by an agonist-activated reccptor/G(s)alpha fusion protein. Proc. nat. Acad. Sci. (Wash.). 91, 8827-8831 (1994).
3. BERTIN, B., JOCKERS, R., STROSBERG, A.D. and MARLLLO, S., Activation of a β2-adrenergic receptor/Gsα fusion protein elicits a desensitization-resistant cAMP signal capable of inhibiting in vitro proliferation of two cancer cell lines. Receptors Channels (1997). (In press).
4. BUCHMANN, A., RUGGIERI, B., KLEIN-SZANTO, A.J.P. and BALMAIN, A., Progression of squamous carcinoma cells to spindle carcinomas of mouse skin is associated with an imbalance of H-ras alleles on chromosome 7. Cancer Res., 51, 4097-1101 (1991).
5. CARDER, P., WYLLIE, A.M., PURDIE, C.A., MORRIS, R.G., WHITE, S., PIRIS, J. and BIRD, C.C., Stabilised p53 facilitates aneuploid clonal divergence in colorectul cancer. Oncogene. 8, 1397-1401 (1993).
6. CRESPO, P., CACHERO, T.G., XU, N. and GUTKIND, J.S., Dual effect of β-adrenergic receptors on mitogen-activated protein kinase. Evidence for a βγ-dependent activation and a Gsot-cAMP mediated inhibition. J. biol. Chem., 270, 25259-25265 (1995).
7. GRIECO, D., PORCELLINI, A., AVVEDIMENTO, E.V. and GOTTESMAN, M.E., Requirement for cAMP-PKA pathway activation by M phase-promoting factor in the transition from mitosis to interphase. Science, 271, 1718-1723 (1996).
8. HAVSDORFF, W.P., HNATOWICH, M., O'DOWD, B.F., CARON, M.G. and LEFKOWITZ, R.J., A mutation of the β2-adrenergic receptor impairs agonist activation of adenilyl cyclase without affecting high affinity agonist binding. J. biol. Chem., 265, 2194-12200 (1990).
9. 1 phase arrest mediated by an inhibitor (p27kip1) of cyclin-deptfiident kinase 4 activation. Cell. 79, 487-496 (1994).
10. MAVORDOMO, J.I., LOFTVS, D.J., SAKAMOTO, H., DE CESARE, C.M., APPASAMY, P.M., LOTZE, M.T., STORKUS, W.J., APPELLA, E. and DELEO, A.B., Therapy of murine tumors with p53 wild-type and mutant sequence peptide-based vaccines. J. exp. Med., 183, 1357-1365 (1996).
11. MONIA, B.P., JOHNSTON, J.F., GEIGER, T., MULLER, M. and FABBRO, D., Antitumor activity of a phosphorothioate antisense oligodeoxynucleotide targeted against C-raf kinase. Nature (Med). 2, 668-675 (1996).
12. MOSMANN, J., Rapid colorimetric assay for cellular growth and survival. J. Immunol. Meth., 65, 55 (1983).
13. NABEL, G.J., YANG, Z.Y., NABEL, E.G., BISHOP, K., MARQUET, M., FELGNER, P.L., GORDON, D. and CHANG, A.E., Direct gene transfer for treatment of human cancer. Ann. N.Y. Acad. Sci., 772, 227-231 (1995).
14. NANDA, N.K. and SERCARZ, E.E., Induction of anti-self-immunity to cure cancer. Cell, 82, 13-17 (1995).
15. NESTEROVA, M. and CHO-CHUNG, Y.S., A single injection protein kinase A-directed antisense treatment to inhibit tumor growth. Nature (Metl.), 1, 528-533 (1995).
16. PAN, Z.K., IKONOMIDIS, G., LAZENBY, A., PARDOLL, D. and PATERSON, Y., A recombinant Listeria monocytogenes vaccine expressing a model tumor antigen protects mice against lethal tumor cell challenge and causes regression of established tumors. Nature (Med.), 1, 471-477 (1995).
17. PAWSON, T. and HUNTER, T., Oncogenes and cell proliferation. Curr. Opin. Genes Develop., 4, 1-4 (1994).
18. PEACE., D.J., SMITH, J.W., CHEN, W., You, S.G., COSAND, W.L., BLAKE, J. and CHEEVER, M., Lysis of ras oncogene-transformed cells by specific cytotoxic T lymphocytes elicited by primary immunization with mutated ras peptide. J. exp. Med., 179, 473-479 (1994).
19. QUINTANILLA, M., HADDOW, S., JONAS, D., JAFFE, D., BOWDEN, G.T. and BALMAIN, A., Comparison of ras activation during epidermal carcinogenesis in vitro and in vivo. Ceircinogenesis, 12, 1875-1881 (1991).
20. STANCOVSKI, I., HURWITZ, E., LEITNER, O., ULLRICH, A., YARDEN, Y. and SELA, M., Mechanistic aspects of the opposing effects of monoclonal antibodies to the ERBB2 receptor on tumor growth. Proc. nat. Acad. Sci. (Wash.). 88, 8691-8695 (1991).
21. TORTORA, G., PFPE, S., BIANCO, C., DAMIANO, V., RUGGIERO, A., BALDASSARRE, G., CORBO, C., CHO-CHUNG, Y.S., BIANCO, A.R. and CIARDIELLO, F., Differential effects of protein kinase A subunits on Chinese hamster ovary cell cycle and proliferation. Int. J. Cancer, 59, 712-716 (1994).
22. TRIPATHY, S.K., BLACK, H.B., GOLDWASSER, E. and LEIDEN, J.M., Immune response to transgene-encoded proteins limit the stability of gene expression after injection of replication-defective adenovirus vectors. Nature (Med.), 2, 545-550 (1996).
23. WANG, M., BRONTE, V., CHEN, P.W., GRITZ, L., PANICALI, D., ROSENBERG, S.A. and RESTIFO, N.P., Active immunotherapy of cancer with non-replicating recombinant fowlpox virus encoding a model tumor-associated antigen. J. Immunol., 154, 4685-1692 (1995).
24. WU, J., DENT, P., JELINEK, T., WOLFMAN, A., WEBER, M.J. and STURGILL, T.W., Inhibition of the EGF-activated MAP kinase signaling pathway by adenosine 3'5'-monophosphate. Science, 262, 1065-1068 (1993).
25. + cytotoxic T cells. Cancer Res., 53, 3257-3261 (1993).